$SRPT
Sarepta Therapeutics,, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SRPT down today? It is at $18.22 (-3.03%), and our scanner flagged it 123 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SRPT spikes, and full due diligence on SRPT — key stats, earnings, dilution and insider activity. Free.
Get free $SRPT alerts the moment volume spikes
Our scanner flagged $SRPT 123 times in the last 30 days. Create a free account to track $SRPT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $18.22
- Change today
- -3.03%
- Previous close
- $18.79
- 52-week range
- $14.68 – $25.32
- Market cap
- $1.98B
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 104K 0% of shares · after <1% insiders + 100% institutions
- Short interest
- 27.6M ▼ -3% vs prior · as of 2026-07-31
- Days to cover
- 8.8d
- Avg daily volume
- 3.9M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 0.0x
- 15mthin
- 0.0x
- 1hthin
- 0.4x
- 1D
- 0.3x
Get free SRPT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $SRPT down today?
SRPT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on SRPT today, peaking at 6.1x its normal volume.
Likely catalystSarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate DevelopmentsReported Net product revenues for the second quarter 2026 totaled $328.7 million, consisting of $230.6 million of PMO net product revenue and $98.1 million of ELEVIDYS net product revenueReported Achieved GAAP and non-GAAP operating income of $13.3 million and $86.5 million for the second quarter 2026, respectivelyReported The most common adverse reactions from observational clinical studies (N=163) seen in greater than 10% of patients were headache, cough, rash, and vomiting., from an SEC filing. Read it →Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $SRPT. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$SRPT Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$SRPT Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to SRPT
Comparable names in pharmaceutical preparations, closest in size first.
SRPT stock FAQ
Why is $SRPT down today?
SRPT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on SRPT today, peaking at 6.1x its normal volume.
What is the SRPT stock price today?
SRPT last traded at $18.22, down 3.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live SRPT alerts?
The SRPT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SRPT 123 times in the last 30 days.
What exchange is SRPT on?
SRPT (Sarepta Therapeutics,, Inc. Common Stock) trades on XNAS, with a market cap of about $1.98B in the PHARMACEUTICAL PREPARATIONS sector.
Is SRPT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SRPT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.